Biogen
Neurology & CNS Therapeutics · Prescription Drugs

Biogen: Ownership & structure

Renaissance Technologies holds 23.4% of Biogen.

Data updated Nov 21, 2026 · Back to the company report

Owners & entities

Renaissance Technologies holds 23.4% of Biogen.

Holders
Legal entities4 in 4 countries
Biogen Inc.
operator · US EIN 330112644
US
subsidiary · GB CRN 01497267
GB
Biogen Finland Oy
related
FI
Biogen Sweden AB
related
SE
Subsidiaries in its annual report: 91 in 45 jurisdictions · Delaware 21, United Kingdom 10, Massachusetts 6, Switzerland 6, Ireland 3 · sec.gov ↗
Stakes and purchases
ownership of shares 75 to 100 percent; voting rights 75 to 100 percent; right to appoint and remove directors
75%
subsidiary (stated on the holder)
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months

Insiders bought $585 (1 people) and sold $905k (2 people) in the last 12 months.

Sold · Director
593 shares at $200.96 · Aug 2026
$119k
Sold · Director
593 shares at $203.34 · Aug 2026
$121k
Bought · Head of Pharm Ops and Tech
3 shares at $195.04 · Feb 2026
$585
Sold · Head of Development
2,660 shares at $199.83 · Feb 2026
$532k
Sold · Head of Development
748 shares at $179.30 · Feb 2026
$134k
Holders and shares as each register or filing states them.